Jamjoom Pharmaceuticals Factory Co. (4015)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Major Shareholders
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

News

23 July 05:03 PM Tadawul registers SAR 166m in total negotiated deals on 23 July

Riyadh – Mubasher: The Saudi Exchange (Tadawul) recorded 13 negotiated deals carried out on five listed entities during the 23 July 2026 session. The implemented transactions held a combined value of SAR 166.04 million through a total of 5.67 …

Company News

23 July 02:48 PM Jamjoom Pharma witnesses negotiated deal of SAR 3.5m

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) recorded a negotiated transaction valued at SAR 3.52 million during the 23 July 2026 session on the Saudi market. The deal, which was carried out at 12:07, comprised …

Stock Evaluations

23 July 12:09 PM Jamjoom Pharma seals binding agreement with PIF-owned Lifera

Riyadh - Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has signed a binding share subscription agreement and a shareholders’ agreement with Lifera, a commercial-scale biopharmaceutical company owned by the Public Investment …

Company News

22 July 04:38 PM Jamjoom Pharma unveils SAR 154m interim dividends for H1-26

Riyadh - Mubasher: The board of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has approved the distribution of SAR 154 million in interim cash dividends to shareholders for the first half (H1) of 2026. The total payout is based on 70 …

Cash Dividends

22 July 11:17 AM Jamjoom Pharma’s net profits up to SAR 306m in H1-26

Riyadh - Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) generated a net profit of SAR 137.63 million for the second quarter (Q2) of 2026, a 4.25% increase from SAR 132.02 million in the prior-year period. The pharmaceutical …

Company News

8 June 11:25 AM Jamjoom Pharma pens MoU to boost healthcare services in Saudi Arabia

Riyadh - Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) inked a memorandum of understanding (MoU) with the General Administration of Pharmaceutical Care at the Ministry of Health Saudi Arabia, according to a press release. The …

Company News

26 April 10:45 AM Jamjoom Pharma logs 7% higher net profits in Q1-26

Riyadh - Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) registered an annual increase of 7.11% in net profits to SAR 168.21 million during the first quarter (Q1) of 2026, compared with SAR 157.03 million. The earnings per share …

Company News

24 February 12:20 PM Jamjoom Pharma’s profits surge 30% in 2025; dividends for H2 unveiled

Riyadh - Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) recorded 30.10% year-on-year (YoY) higher net profits attributable to the shareholders at SAR 463.80 million in 2025, compared with SAR 356.50 million. The earnings per …

Financial Results

29 October 2025 07:42 AM Jamjoom Pharma, PIF-backed Lifera launch JV to strengthen Saudi biopharma manufacturing ecosystem

Riyadh - Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) signed a non-binding term sheet with Pharmaceutical Investment Company (Lifera), a Public Investment Fund (PIF) entity, on 27 October. The term sheet aims to form a joint …

Companies Investments

23 October 2025 01:09 PM Jamjoom Pharma’s net profits near SAR 396m in 9M-25

Riyadh – Mubasher: The net profits after tax of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) reached SAR 395.73 million in the first nine months (9M) of 2025, an annual rise of 29.78% from SAR 304.92 million. The group recorded 12.96% …

Financial Results

5 October 2025 08:18 AM Jamjoom Pharma launches new brand identity to accelerate regional growth

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) rolled out its new corporate brand identity, marking the next phase of its strategic evolution towards being a leading global player in the pharmaceutical industry. The …

Companies Investments

16 September 2025 08:46 AM Jamjoom Pharma partners with Bio-Thera to secure Cosentyx biosimilar in MENA

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has signed a strategic commercialization agreement with Bio-Thera Solutions Limited, a global biopharmaceutical firm specializing in innovative therapies and biosimilars. …

Global Economy

1 July 2025 05:15 PM Jamjoom Pharma appoints new Chairman, Vice Chairman

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has named Mahmoud Yousuf Jamjoom as the board’s Chairman for the next three years. The board also announced Ahmed Yousuf Jamjoom as the Vice Chairman, according to a …

Board of Directors

30 April 2025 09:16 AM Jamjoom Pharma logs SAR 157m net profits in Q1-25

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) achieved net profits amounting to SAR 157.03 million in the first quarter (Q1) of 2025, an annual growth of 52.50% from SAR 102.97 million. Revenues soared by 18.69% to …

Financial Results

25 February 2025 08:42 PM Jamjoom Pharma registers 22% higher profits backed by expansion in Egypt

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) posted 21.93% higher net profits at SAR 356.52 million in 2024, compared to SAR 292.40 million in 2023. Revenues jumped by 19.77% year-on-year (YoY) to SAR 1.31 billion as …

Cash Dividends

15 January 2025 03:28 PM Jamjoom Pharma partakes in 43rd J.P. Morgan Healthcare Conference 2025

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) is participating in the 43rd Annual J.P. Morgan Healthcare Conference that is taking place in the US, according to a press release. The conference is being held on 13-16 …

Companies Investments

5 January 2025 10:09 PM TASI expected to trade between 11,300 to 13,300pts in 2025 – Report

Riyadh – Mubasher: SNB Capital, a regional financial institution, recently projected in a report that the benchmark All Share Index (TASI) of the Saudi Exchange (Tadawul) would trade between 11,300 to 13,300 points (pts) in 2025, reflecting a …

Trading Activities

27 October 2024 00:40 PM Jamjoom Pharma posts SAR 305m net profits in 9M-24

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) achieved net profits valued at SAR 304.92 million in the first nine months (9M) of 2024, marking a 22.90% year-on-year (YoY) leap from SAR 247.92 million. The revenues hit …

Financial Results

7 August 2024 02:47 PM Jamjoom Pharma’s profits rise 23% in H1-24; dividends unveiled

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) logged net profits amounting to SAR 209.92 million in the first half (H1) of 2024, marking an annual plunge of 22.99% from SAR 170.67 million. The revenues hit SAR 731.20 …

Financial Results

8 July 2024 09:15 AM Jamjoom Pharma secures facility deal for unit in Algeria

Riyadh – Mubasher: The board of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) agreed to provide a corporate guarantee to support the issuance of a credit facility for its joint venture (JV) in Algeria, Jamjoom Algeria Lil Dawa SPA. A …

Companies Investments

5 June 2024 11:33 AM Jamjoom Pharma’s shareholders approve annual dividends for 2023

Riyadh – Mubasher: The extraordinary general meeting (EGM) of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) approved cash dividends amounting to SAR 105 million for the second half (H2) of 2023. The total dividends distributed and …

Cash Dividends

9 May 2024 00:08 PM Jamjoom Pharma registers SAR 103m net profits in Q1-24

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) achieved 22% year-on-year (YoY) higher net profits at SAR 102.96 million in the first quarter (Q1) of 2024, versus SAR 84.40 million. Revenues amounted to SAR 385.46 …

Financial Results

4 April 2024 02:12 PM Jamjoom Pharma’s board proposes SAR 105m dividends

Riyadh – Mubasher: The board of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) recommended the distribution of SAR 105 million in cash dividends for 2023. The suggested dividends amount to SAR 1.50 per share to be distributed to 70 …

Cash Dividends

25 March 2024 00:32 PM Jamjoom Pharma posts 71% YoY higher profit in 2023

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) logged a 70.68% year-on-year (YoY) jump in net profit to SAR 292.40 million in 2023 from SAR 171.31 million. Revenues grew 20.09% YoY to SAR 1.10 billion last year from …

Financial Results

21 January 2024 04:05 PM Jamjoom Pharma secures funding to back JV in Algeria

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has secured a short-term revolving banking facility from the Bank of NATIXIS Algeria with a total amount of DZD 1.30 billion (SAR 36.20 million). The loan will support the …

Companies Investments